Mesothelioma News

News headlines courtesy the Mesothelioma Center.

Actor Steve McQueen, Beloved Husband of Barbara McQueen, Honored Posthumously with the Warren Zevon ?Keep Me in Your Heart? Memorial Tribute Award

January 13, 2012 - The Asbestos Disease Awareness Organization (ADAO) today announced that it is honoring Steve McQueen with the Warren Zevon "Keep Me in Your Heart" Memorial Tribute Award. McQueen, a global cinema legend in the 1960s and 1970s, passed away in 1980 from the asbestos-related cancer, mesothelioma. The Warren Zevon Tribute will be presented at noon on [...]

Annual Asbestos Awareness Day Grows into a Global Asbestos Awareness Week

March 28, 2011 - For more than a hundred years, knowledge of asbestos’ risks has been well documented. However, despite the seemingly widespread understanding that asbestos exposure kills, it was only seven years ago, on April 1, 2005 that the first "National Asbestos Awareness Day" was held. Perhaps even more amazing is the comparatively short chain of events starting, [...]

Smoking and Lung Cancer Not the End of the Story: Asbestos and Smoking Create an Incredibly Deadly Combination

March 22, 2011 - Lung cancer is the most common type of cancer worldwide, resulting in 1.4 million deaths annually1. In the US, more than 150,000 deaths resulted from lung cancer in 20102. Although lung cancer can have numerous causes, smoking is a huge and well-known contributor to lung cancer deaths, with some 90% of all lung cancer cases [...]

ADAO Praises Senate for Introduction of Seventh Annual Resolution that Establishes ?National Asbestos Awareness Week?

February 22, 2011 - The Asbestos Disease Awareness Organization (ADAO), combining education, advocacy and community as the leading U.S. organization serving as the voice of asbestos victims, today applauds Senator Max Baucus (D-MT) and cosponsors for introducing a resolution that declares the first week of April as "National Asbestos Awareness Week" and seeks to "raise public awareness about the [...]

Raltitrexed (Tomudex®) in Combination With Cisplatin in the Treatment of MPM Improves Overall Survival Compared to Treatment With Cisplatin Alone

October 12, 2010 - Raltitrexed (Tomudex®) in Combination With Cisplatin in the Treatment of MPM Improves Overall Survival Compared to Treatment With Cisplatin Alone1 MPM is a Rare Cancer, but its Incidence is Expected to Double Over the Next 20 Years in Many Countries2 Raltitrexed is Currently Licensed for the Treatment of MPM in Portugal, Czech Republic and Hungary; [...]

ADAO Applauds Assembly Committee on Natural Resources for Passing Resolution to Repeal the Designation of Asbestos Laden Serpentine as the California State Rock

June 25, 2010 - The Asbestos Disease Awareness Organization (ADAO) applauds both Senator Gloria Romero for authoring SB 624 and the Assembly Committee on Natural Resources for passing this legislation to remove serpentine, the host rock of asbestos, as California?s official state rock, supporting the eradication of asbestos to promote public health. ?ADAO dedicates our efforts on this campaign [...]

Senator Max Baucus Honored by Mesothelioma Applied Research Foundation

June 18, 2010 - On June 11, 2010 Senator Max Baucus, the United States Senator from Montana, received the Bruce Vento Hope Builder Award during the International Symposium on Malignant Mesothelioma. This event, hosted by the Mesothelioma Applied Research Foundation (Meso Foundation) took place in Washington, DC from June 10 ? 12, 2010 at the Omni Shoreham Hotel. This [...]

Experts Urge Canada to Change Deadly Asbestos Policy

May 10, 2010 - World renowned experts, asbestos victims, labour, political leaders, academic researchers and health care providers will gather on Parliament Hill on May 12 to demand that Canada change its shameful course on asbestos, at a 11 a.m. press conference and subsequent rally. They will also call for just transition policies for communities relying on this industry. [...]

MolMed starts Phase III trial of NGR-hTNF in mesothelioma

April 20, 2010 - MolMed S.p.A. (Milan:MLM) announces the treatment of the first patient in a pivotal Phase III trial (NGR015) of its investigational antitumour drug NGR-hTNF in malignant pleural mesothelioma, a condition linked with repeated exposition to asbestos fibers. Claudio Bordignon, MolMed?s chairman and CEO, comments: ?We are really proud of this important milestone, as NGR-hTNF may represent [...]

microRNAs Shown To Have Powerful Potential as Diagnostic and Prognostic Markers In A Variety Of Cancer Indications

April 13, 2010 - Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostic tests, announced today it will present multiple posters at the upcoming American Association of Cancer Research’s (AACR) 101st Annual Meeting to be held at the Walter E. Washington Convention Center in Washington, D.C. from April 17-21, 2010. The posters will include data on [...]

Contact Us